Institutional investors purchased a net $2.0 million shares of SNTA during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 40.72% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
| Individual stakeholders | 35.13% |
| Other institutional | 22.98% |
| Mutual fund holders | 17.75% |